Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B

Transient Hepatitis B Surface Antigenemia Following Immunization with Heplisav-B

Objective: To delineate the rate and duration of transient hepatitis B surface antigenemia following Heplisav-B vaccination. Patients and Methods: We retrospectively reviewed the medical records of all adult patients who received Heplisav-B vaccination at our institution from January 1, 2019, throug...

Full description

Bibliographic Details
Main Authors: Cristina Corsini Campioli, MD, Zerelda Esquer Garrigos, MD, Mariam Assi, MD, John Raymond Go, MD, Raymund R. Razonable, MD, Elena Beam, MD, Joseph Yao, MD, Nathan W. Cummins, MD
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Online Access:http://www.sciencedirect.com/science/article/pii/S2542454820302526

Internet

http://www.sciencedirect.com/science/article/pii/S2542454820302526

Similar Items